DK1869048T3 - Fremgangsmåde til fremstilling af alpha-form-krystaller af sapropterinhydrochlorid - Google Patents

Fremgangsmåde til fremstilling af alpha-form-krystaller af sapropterinhydrochlorid

Info

Publication number
DK1869048T3
DK1869048T3 DK06732122T DK06732122T DK1869048T3 DK 1869048 T3 DK1869048 T3 DK 1869048T3 DK 06732122 T DK06732122 T DK 06732122T DK 06732122 T DK06732122 T DK 06732122T DK 1869048 T3 DK1869048 T3 DK 1869048T3
Authority
DK
Denmark
Prior art keywords
sapropterin hydrochloride
form crystals
degrees
preparing alpha
crystals
Prior art date
Application number
DK06732122T
Other languages
Danish (da)
English (en)
Inventor
Hiroomi Kiyono
Katsumi Hotoda
Shinnosuke Tazawa
Original Assignee
Shiratori Pharm
Asubio Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shiratori Pharm, Asubio Pharma Co Ltd filed Critical Shiratori Pharm
Application granted granted Critical
Publication of DK1869048T3 publication Critical patent/DK1869048T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D475/00Heterocyclic compounds containing pteridine ring systems
    • C07D475/02Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4
    • C07D475/04Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4 with a nitrogen atom directly attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
DK06732122T 2005-04-14 2006-04-13 Fremgangsmåde til fremstilling af alpha-form-krystaller af sapropterinhydrochlorid DK1869048T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2005116687 2005-04-14
PCT/JP2006/308264 WO2006112495A1 (fr) 2005-04-14 2006-04-13 Procede de production de cristaux de chlorhydrate de sapropterine de forme alpha

Publications (1)

Publication Number Publication Date
DK1869048T3 true DK1869048T3 (da) 2009-03-09

Family

ID=36617398

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06732122T DK1869048T3 (da) 2005-04-14 2006-04-13 Fremgangsmåde til fremstilling af alpha-form-krystaller af sapropterinhydrochlorid

Country Status (15)

Country Link
US (1) US8039617B2 (fr)
EP (1) EP1869048B8 (fr)
JP (1) JP4980230B2 (fr)
KR (1) KR101258430B1 (fr)
CN (1) CN101160310B (fr)
AT (1) ATE415403T1 (fr)
AU (1) AU2006237936B2 (fr)
BR (1) BRPI0608863B1 (fr)
CA (1) CA2604818C (fr)
DE (1) DE602006003883D1 (fr)
DK (1) DK1869048T3 (fr)
ES (1) ES2317529T3 (fr)
PL (1) PL1869048T3 (fr)
PT (1) PT1869048E (fr)
WO (1) WO2006112495A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2010007452A (es) 2008-01-07 2010-08-18 Biomarin Pharm Inc Metodo para sintetizar tetrahidrobiopterin.
US9216178B2 (en) 2011-11-02 2015-12-22 Biomarin Pharmaceutical Inc. Dry blend formulation of tetrahydrobiopterin
CN108033963A (zh) * 2017-12-29 2018-05-15 天津凯莱英制药有限公司 沙丙喋呤二盐酸盐晶型b及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60178887A (ja) 1984-02-23 1985-09-12 Kanegafuchi Chem Ind Co Ltd 5,6,7,8−テトラヒドロ−l−ビオプテリンの製造法
US4713454A (en) * 1985-01-28 1987-12-15 Shiratori Pharmaceutical Co., Ltd. Preparation process of (6R)-tetrahydro-L-biopterin
JPS61172876A (ja) * 1985-01-28 1986-08-04 Shiratori Seiyaku Kk (6r)−テトラヒドロ−l−バイオプテリンの製造法
JP2711828B2 (ja) 1996-06-25 1998-02-10 白鳥製薬株式会社 (6r)−テトラヒドローl−バイオプテリン塩酸塩の製造法
JP2007536210A (ja) * 2003-11-17 2007-12-13 メルック・エプロバ・アクチエンゲゼルシヤフト (6r)−l−エリスロ−テトラヒドロビオプテリンジヒドロクロライドの結晶形

Also Published As

Publication number Publication date
PT1869048E (pt) 2009-03-05
US20090270619A1 (en) 2009-10-29
ATE415403T1 (de) 2008-12-15
AU2006237936A1 (en) 2006-10-26
WO2006112495A1 (fr) 2006-10-26
JP2008535770A (ja) 2008-09-04
CA2604818C (fr) 2012-12-04
KR101258430B1 (ko) 2013-04-26
CA2604818A1 (fr) 2006-10-26
KR20080000582A (ko) 2008-01-02
AU2006237936B2 (en) 2011-06-16
DE602006003883D1 (de) 2009-01-08
EP1869048A1 (fr) 2007-12-26
ES2317529T3 (es) 2009-04-16
EP1869048B1 (fr) 2008-11-26
BRPI0608863B1 (pt) 2022-09-27
BRPI0608863A2 (pt) 2010-02-02
US8039617B2 (en) 2011-10-18
EP1869048B8 (fr) 2009-04-15
JP4980230B2 (ja) 2012-07-18
CN101160310B (zh) 2010-05-26
PL1869048T3 (pl) 2009-05-29
CN101160310A (zh) 2008-04-09

Similar Documents

Publication Publication Date Title
EA201100571A1 (ru) Получение кремния для солнечных батарей из диоксида кремния
ATE450488T1 (de) Lichtreaktives polymer und verfahren zu seiner herstellung
NO20076658L (no) Heteroarylbenzamidderivater for anvendelse som GLK aktivatorer ved behandling av diabetes
DK2057126T3 (da) Fremgangsmåde til fremstilling af 3-dihalomethyl-pyrazol-4-carboxylsyrederivater
JP2016513478A5 (fr)
NO20075707L (no) Syntese av bis(tio-hydrazid-amid)salter
DE502006006107D1 (de) Amid substituierte 8-n-benzimidazole, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
CR8975A (es) Proceso para la produccion de derivados de amina opticamente activos
JP2013502377A5 (fr)
WO2008114332A1 (fr) Procédé pour produire un film polymère transparent, film polymère transparent produit par celui-ci, film de retardement, plaque de polarisation et appareil d'affichage à cristaux liquides
EP2389243A4 (fr) Synthèse de catalyseur palladium-or
AR056082A1 (es) Formas cristalinas de clorhidrato de irinotecano (monoclorhidrato de 7-etil-10-[4-(1-piperidin)-1-piperidin]carboniloxicamptotecina trihidratado) y metodos de preparacion de las mismas
DK1869048T3 (da) Fremgangsmåde til fremstilling af alpha-form-krystaller af sapropterinhydrochlorid
MX2010001094A (es) Trazodona y hidrocloruro de trazodona en forma purificada.
BR112013023880A2 (pt) vidro plano e processo para produzir o mesmo
AR081267A1 (es) Procedimiento de obtencion de la forma cristalina a del febuxostat
DK2152667T3 (da) Fremgangsmåder til fremstilling af N-isobutyl-n-(2-hydroxy-3-amin-4-phenylbutyl)-p-nitrobenzenesulfonylamid-derivater
BR112013032901A2 (pt) processo para fabricação de derivados de hidroxietilamido
GB2527466A (en) A method of treating a high-temperature well with a fluid containing a viscosifier and a stabilizer package
WO2008129757A1 (fr) Procédé de fabrication d'un bisphénol a
NZ606180A (en) (20r,25s)-2-methylene-19,26-dinor-1α, 25-dihydroxyvitamin d3 in crystalline form
ATE509619T1 (de) Herstellungsverfahren für eine feste dispersion mit itraconazol
BR112013031080A2 (pt) processo para preparar uma alquil diamina, processo para preparar 2-metil-1,2-diaminopropano e composição
RU2007139616A (ru) Способ получения цис-дихлородиметиламинплатины(ii)
CL2012001528A1 (es) Proceso para preparar la forma cristalina a de ilaprazol a partir de una sal inorganica de ilaprazol y posterior neutralizacion de la sal con un acido en un solvente de reaccion; y proceso para preparar la forma cristalina b de ilaprazol en la forma cristalina a de ilaprazol.